Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001209191-24-000783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-04 | 2024-01-02 | PCVX | Lukatch Heath | Dir | S - Sale+OE | $63.76 | -13.0K | 5,625 | -70% | -$828.9K |
| D | 2024-01-04 | 2024-01-02 | PCVX | Lukatch Heath | Dir | M - OptEx | $16.00 | +13.0K | 18.6K | +231% | +$208.0K |
| D | 2024-01-04 | 2024-01-02 | PCVX | Lukatch Heath | Dir | M - OptEx | $0.00 | -13.0K | 15.0K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | S | D | 1,101 | $62.85 | 17,524 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $62.01 to $62.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-01-02 | S | D | 7,444 | $63.55 | 10,080 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $63.01 to $64.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-01-02 | S | D | 4,164 | $64.28 | 5,916 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $64.015 to $64.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-01-02 | S | D | 291 | $65.19 | 5,625 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $65.12 to $65.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-01-02 | M | A | 13,000 | $16.00 | 18,625 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2024-01-02 | M | D | 13,000 | $0.00 | 15,000 | D | $16.00 · — to 2030-06-10 | 13,000 Common Stock | (F6) Fully vested and exercisable. |